Xuebijing injection improves the respiratory function in rabbits with oleic acid‑induced acute lung injury by inhibiting IL‑6 expression and promoting IL‑10 expression at the protein and mRNA levels

  • Authors:
    • Yuxia Wang
    • Mingli Ji
    • Lei Wang
    • Liping Chen
    • Jing Li
  • View Affiliations

  • Published online on: September 5, 2014     https://doi.org/10.3892/etm.2014.1949
  • Pages: 1593-1598
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Xuebijing injection is a complex herbal medicine, and clinical and experimental studies have shown that it has a significant effect on acute respiratory distress syndrome and multiple organ dysfunction syndrome. However, the majority of studies regarding Xuebijing injection have focused on serum inflammatory factors, and few studies have been carried out from the perspective of the protein and mRNA expression of inflammatory cytokines. In this study, 60 healthy rabbits of mixed gender were randomly assigned to a normal control group (CG), oleic acid group (model group; MG) and oleic acid + Xuebijing injection group (treatment group; TG). Rabbits of the CG were treated with normal saline through the ear vein, rabbits of the MG were injected with oleic acid (0.4 ml/kg) and rabbits of the TG received 0.4 ml/kg oleic acid + 10 ml/kg Xuebijing injection. Blood samples were collected from the common carotid artery of all rabbits of all groups 1 h after the ear vein was injected with the corresponding reagent, and was used to measure the arterial partial pressure of oxygen (PaO2) and of carbon dioxide (PaCO2). The activity of myeloperoxidase (MPO) was tested, and the protein and mRNA expression levels of interleukin (IL)‑6 and IL‑10 were determined. Rabbits of the MG exhibited evident respiratory dysfunction (PaO2 and PaCO2 were low), histopathological lung damage and overactive inflammatory responses (the expression of the proinflammatory cytokine IL‑6 and the anti‑inflammatory cytokine IL‑10 was increased at the protein and mRNA levels). Following the administration of the Xuebijing injection, the inflammatory response of the rabbits was significantly reduced. Xuebijing injection raised PaO2 and PaCO2, weakened the activity of MPO in the lung tissue, downregulated the expression of the proinflammatory cytokine IL‑6 and further increased the expression of the anti‑inflammatory cytokine IL‑10. These results demonstrated that Xuebijing injection improved the respiratory function of rabbits with acute oleic acid‑induced lung injury by inhibiting IL‑6 expression and promoting IL‑10 expression.
View Figures
View References

Related Articles

Journal Cover

November-2014
Volume 8 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang Y, Ji M, Wang L, Chen L and Li J: Xuebijing injection improves the respiratory function in rabbits with oleic acid‑induced acute lung injury by inhibiting IL‑6 expression and promoting IL‑10 expression at the protein and mRNA levels. Exp Ther Med 8: 1593-1598, 2014
APA
Wang, Y., Ji, M., Wang, L., Chen, L., & Li, J. (2014). Xuebijing injection improves the respiratory function in rabbits with oleic acid‑induced acute lung injury by inhibiting IL‑6 expression and promoting IL‑10 expression at the protein and mRNA levels. Experimental and Therapeutic Medicine, 8, 1593-1598. https://doi.org/10.3892/etm.2014.1949
MLA
Wang, Y., Ji, M., Wang, L., Chen, L., Li, J."Xuebijing injection improves the respiratory function in rabbits with oleic acid‑induced acute lung injury by inhibiting IL‑6 expression and promoting IL‑10 expression at the protein and mRNA levels". Experimental and Therapeutic Medicine 8.5 (2014): 1593-1598.
Chicago
Wang, Y., Ji, M., Wang, L., Chen, L., Li, J."Xuebijing injection improves the respiratory function in rabbits with oleic acid‑induced acute lung injury by inhibiting IL‑6 expression and promoting IL‑10 expression at the protein and mRNA levels". Experimental and Therapeutic Medicine 8, no. 5 (2014): 1593-1598. https://doi.org/10.3892/etm.2014.1949